Related references
Note: Only part of the references are listed.Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial
Amir Sonnenblick et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials
Marian L. Neuhouser et al.
JAMA ONCOLOGY (2015)
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
M. Piccart et al.
ANNALS OF ONCOLOGY (2014)
Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor-Positive Breast Cancer
Enrique Fuentes-Mattei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer
Francisco J. Esteva et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin
Piotr J. Wysocki et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Relation of body mass index (BMI) to disease free (DFS) and distant disease free Survivals (DDFS) among Turkish women with operable breast carcinoma
Binnaz Demirkan et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Estradiol regulates the insulin-like growth factor-I (IGF-I) signalling pathway: A crucial role of phosphatidylinositol 3-kinase (PI 3-kinase) in estrogens requirement for growth of MCF-7 human breast carcinoma cells
Laurence Bernard et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Obesity and prognosis of breast cancer
A. R. Carmichael
OBESITY REVIEWS (2006)
Body mass and mortality after breast cancer diagnosis
MK Whiteman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1
A Mawson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects
J Dupont et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Share Paper
